Novel Therapies for the Treatment of Newly Diagnosed Multiple Myeloma

Novel Therapies for the Treatment of Newly Diagnosed Multiple Myeloma
Novel Therapies for the Treatment of Newly Diagnosed Multiple Myeloma
CME, CPE
Shaji K. Kumar, MD
Release Date: June 27, 2018
Expiration Date: June 27, 2019

When managing newly diagnosed multiple myeloma (MM) patients, recommended diagnostic and treatment strategies are critical for optimizing outcomes. This activity will address how upfront testing strategies and current risk stratification processes support the identification of treatments that are tailored to each patient’s unique characteristics and needs.

Provided by MediCom Worldwide, Inc.
This activity is supported by educational grants from Amgen, Inc., Bristol-Myers Squibb, Celgene Corporation, and Takeda Oncology
Begin, Earn CreditView Only, No CreditGet Certificate